Veterinary Compounding for Myasthenia Gravis

Author(s):  Davidson Gigi S

Issue:  Sep/Oct 2008 - Veterinary Compounding
View All Articles in Issue

Abstract:  Myasthenia gravis is a neuromuscular disease commonly encountered in veterinary medicine. With accurate diagnosis, treatment, and compliant caregivers, the prognosis for remission and a normal life is good. Unfortunately, drugs used to diagnose and treat myasthenia gravis are frequently unavailable due to manufacturer shortages. During these periods, compounding pharmacists can play a valuable role in maintaining a good quality of life for these patients by providing compounded versions of drugs that are commercially unavailable.

Related Keywords: formulations, myasthenia gravis, muscle disorders, dogs, veterinary medicine, muscle weakness, cats, edrophomium hydrochloride, acetylcholinesterase inhibitor, acetycholine, neurotransmitter, anticholinesterase agents, pyridostigmine bromide, cellulose, methylcellulose, excipients

Related Categories: EXCIPIENTS, FORMULATIONS, VETERINARY, MUSCULOSKELETAL DISORDERS, NEUROLOGY

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=2820

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products